Linget
Jean-Michel Linget, Hoersholm DK
Patent application number | Description | Published |
---|---|---|
20100144701 | Modulators of CB1 Receptors - Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention of weigh gain, treatment of diseases and conditions directly or indirectly associated with obesity and overweight: wherein A | 06-10-2010 |
20100292273 | Cannabinoid Receptor Modulators - Compounds of formula (I) are modulators of cannabinoid receptor CB1, useful inter alia for treatment of obesity: Formula (I). Wherein: X is a bond, or a divalent radical selected from —C(R | 11-18-2010 |
Jean-Michel Linget, Hoersholm FR
Patent application number | Description | Published |
---|---|---|
20100010061 | CB1 RECEPTOR MODULATORS - Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention of weigh gain, treatment of diseases and conditions directly or indirectly associated with obesity and overweight: | 01-14-2010 |
Jean-Michel Linget, Benfeld FR
Patent application number | Description | Published |
---|---|---|
20130158090 | METRONIDAZOLE ESTERS FOR TREATING ROSACEA - A compound of formula (I): | 06-20-2013 |
20130178633 | PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF - The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): | 07-11-2013 |
20130197048 | METRONIDAZOLE ESTERS FOR TREATING ROSACEA - A compound of formula (I): | 08-01-2013 |
20130217740 | METRONIDAZOLE ESTERS FOR TREATING ROSACEA - A compound of formula (I): | 08-22-2013 |